Leaderboard
Anzeige
medline.ch
En
|
De
Impressum
No articles selected!
View Cart
You are here:
Respiratory Tract
»
Neoplasms
23. May 2026
Search
medline.ch
Neoplasms
Advanced search
Dermatology
Endocrinology
Nutrition
Gastroenterology
Gynecology
Haematology
Infectious diseases
Cardiovascular Diseases
Musculoskeletal Diseases
Neurology
Oncology
ORL
Pediatrics
Psychiatry
Respiratory Tract
Allergic Rhinitis - Hay Fever
Asthma
Bronchitis
COPD
Interstitial Lung Diseases
Pulmonary Embolism
Neoplasms
Pleural Diseases
Pneumonia
SARS
Sleep Apnoe Disorder
Tuberculosis
Cystic Fibrosis
Sports
Urology-Nephrology
Rect Top
Anzeige
Zoom:
Page 1 of 7992
Articles 1 - 20 / 159822
The evolving disease burden of lung cancer (2014-2023) in Qingdao, China: An observational trend study with projections.
Medicine (Baltimore)
Bai Y, Xue X, Zhao Y, Li F, Jin Z, Li K, Duan H, Wu Y, Zhang H.
PMID: 42175468 [PubMed - indexed for MEDLINE]
Causal effects of plasma protein-protein ratios on lung cancer subtypes: A proteome-wide Mendelian randomization and mediation analysis.
Medicine (Baltimore)
Geng X, Xue J, Liu K, Song Z, Wang Y, Cao X, Li Z, Chen L.
PMID: 42175454 [PubMed - indexed for MEDLINE]
Applying digital technologies for remote care in the real life context: A 3-year experimentation with postoperative lung cancer patients.
Medicine (Baltimore)
Tang D, Wang J, Fu W, Yang F, Mo N, Li S, Niu Y, Wu Y, Zhang H, Shen X, Gao W.
PMID: 42175423 [PubMed - indexed for MEDLINE]
Explainable Multitask Transformers for Early Detection of Smoking Behaviors and Lung Cancer Symptoms from Danish Electronic Health Records.
Stud Health Technol Inform
Sorayaie Azar A, Wiil UK, Henriksen MBH, Bagherzadeh Mohasefi J, Hilberg O, Naemi A, Ebrahimi A.
PMID: 42174984 [PubMed - indexed for MEDLINE]
Development of a Hybrid Algorithm of Claims Data and EMRs with NLP for Lung Cancer Identification.
Stud Health Technol Inform
Sugimoto K, Wada S, Konishi S, Okada K, Takeda T.
PMID: 42174971 [PubMed - indexed for MEDLINE]
Effects of Non-IID Distributions in Lung Cancer Data on Survival Prediction with Federated Ensemble Learning.
Stud Health Technol Inform
Weber L, Hauschild AC, Altenbuchinger M, Sax U, Hügel J.
PMID: 42174793 [PubMed - indexed for MEDLINE]
Trends in cardiovascular mortality among lung cancer patients in the United States: a retrospective study from 1999 to 2023.
Cardiooncology
Chen YL, Chen JQ, Zeng LW, Wu JY, Qiu XX, Lin ZN, Xiao J, Miao X, Wang RH, Zhang JC.
PMID: 42174724 [PubMed - as supplied by publisher]
Does the lung cancer screening (LCS) pathway independently improve surgical outcomes compared with the routine pathway: a matched-case analysis.
J Cardiothorac Surg
Mathur A, Alzahrani M, Abid A, Djearaman M, Glynn P, Maddekar N, Naidu B.
PMID: 42174716 [PubMed - as supplied by publisher]
Development of a multifactorial prediction model for symptomatic radiation pneumonitis in lung cancer patients undergoing stereotactic body radiotherapy.
Radiat Oncol
Yang X, Wang Q, Ruan C, Wang L, Gong H, Huang D.
PMID: 42174644 [PubMed - as supplied by publisher]
Real-World Data of Second-Line Amrubicin Monotherapy in Patients With Extensive-Stage Small Cell Lung Cancer Who Received First-Line Chemoimmunotherapy or Chemotherapy: A Multicenter Retrospective Study.
Cancer Med
Sonehara K, Tsutsui T, Nozawa S, Agatsuma T, Yamamoto M, Matsuo A, Nakanishi M, Chiaki T, Kato A, Miyahara T, Hachiya T, Kanda S, Hirabayashi T, Yanagisawa K, Araki T, Tateishi K, Hanaoka M.
PMID: 42174384 [PubMed - indexed for MEDLINE]
Functional and mechanistic inactivation of immune hubs orchestrates tumor development and progression in lung adenocarcinoma.
Discov Oncol
Alghamdi A, Alissa M.
PMID: 42174277 [PubMed - as supplied by publisher]
Deep learning and radiomics models in patients with advanced non-small cell lung cancer treated with immunotherapy combined with stereotactic radiotherapy.
Sci Rep
Kothari G, Hardcastle N, Perera R, Jackson P, Lee S, Silver JD, Gaudreault M, Li J, Brown C, Mitchell PLR, Kron T, Welsh JW, Theelen WSME, Siva S.
PMID: 42174085 [PubMed - as supplied by publisher]
Weekend admission and outcomes in cancer-associated pulmonary embolism: a cross-sectional national inpatient sample study, 2016-2022.
Sci Rep
Zhang X, Xiao N, San BJ, Du S, Yang Z, Lee CH.
PMID: 42173903 [PubMed - as supplied by publisher]
[Subacute pulmonary coccidioidomycosis: A differential diagnosis of lung cancer].
Rev Mal Respir
Le Gac C, Hamane S, Costantini A, Leprieur EG, Wang P.
PMID: 42173732 [PubMed - as supplied by publisher]
Predicting Radiation-Induced Esophagitis in Locally Advanced NSCLC Using Baseline Clinical Factors: A Model From the Japan Lung Cancer Society Integrated Phase II-III Database.
Clin Lung Cancer
Uehara Y, Watanabe K, Tamura J, Ozawa Y, Yomota M, Kishino K, Kobayashi T, Taguchi K, Murofushi KN, Oizumi S, Hotta K, Shimokawa T, Niho S, Sugawara S, Okamoto I, Yamamoto K, Yamamoto N, Hosomi Y.
PMID: 42173719 [PubMed - as supplied by publisher]
Hypertrophic pulmonary osteoarthropathy in bilateral distal tibia and fibula.
BMJ Case Rep
Inoue F, Taki M, Oshima K, Ukita H.
PMID: 42173542 [PubMed - indexed for MEDLINE]
Pneumocystis jirovecii pneumonia infection in a patient with small cell lung cancer complicated by hypercortisolaemia and lymphopaenia.
BMJ Case Rep
Pennington S, Prasad AB, Murphy S.
PMID: 42173538 [PubMed - indexed for MEDLINE]
Long-term outcomes after proton therapy vs. intensity-modulated photon radiotherapy with concurrent chemotherapy for locally advanced non-small-cell lung cancer: post-hoc analysis of a prospective randomized trial.
Int J Radiat Oncol Biol Phys
Su T, Xu T, Chen M, Chen X, Nguyen QN, Chun SG, Lin SH, Chang JY, Heymach JV, Tsao A, Deswal A, Koutroumpakis E, Qian D, Bronk J, Ning M, Chen A, O'Reilly M, Gandhi S, Fossella FV, Jr GRB, Vaporciyan AA, Swisher SG, Lu CS, Mohan R, Zhang X, Lee JJ, Liao Z.
PMID: 42173326 [PubMed - as supplied by publisher]
Racial and ethnic differences in prostate cancer screening outcomes in the United States: A secondary analysis of the prostate, lung, colorectal, and ovarian cancer trial.
Prev Med
Joung HH, Martin DN, Jones RA.
PMID: 42173201 [PubMed - as supplied by publisher]
ARID1A loss drives osimertinib resistance by epigenetically suppressing PTEN and activating the Akt pathway in lung cancer.
Biochem Biophys Res Commun
Pan X, Sun X, Huang Z, Pei Y, Shi M.
PMID: 42172903 [PubMed - as supplied by publisher]
Articles 1 - 20 / 159822
Page 1 of 7992
Rect Bottom
Anzeige
Adserver Footer
Time frame
--unlimited--
1 Week
1 Month
3 Months
6 Months
1 Year
2 Years
3 Years
5 Years
10 Years
Sky right 1
Anzeige
Mediscope AG E-mail:
info@mediscope.ch
Disclaimer
|
Privacy Policy